These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7695721)

  • 1. Iron overload and response to alpha-interferon in chronic hepatitis C.
    Girelli CM; Mirata C; Lesinigo E; Casiraghi A
    Am J Gastroenterol; 1995 Jan; 90(1):170-1. PubMed ID: 7695721
    [No Abstract]   [Full Text] [Related]  

  • 2. Response of chronic hepatitis C to interferon-alpha treatment and relationship with iron metabolism.
    Martín-Vivaldi R; Nogueras F; González A; Quintero D; Pinel LM; Castro T; Hernández A
    Rev Esp Enferm Dig; 1997 Jul; 89(7):523-30. PubMed ID: 9265838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic hepatitis treated with alpha-interferon].
    Michael M
    Orv Hetil; 1992 Jul; 133 Suppl 1():63-5. PubMed ID: 1630805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic hepatitis C with alpha-interferon.
    Marcellin P
    Eur J Med; 1992; 1(4):194-5. PubMed ID: 1341443
    [No Abstract]   [Full Text] [Related]  

  • 5. Exacerbation of psoriasis due to interferon-alpha treatment of chronic active hepatitis.
    Georgetson MJ; Yarze JC; Lalos AT; Webster GF; Martin P
    Am J Gastroenterol; 1993 Oct; 88(10):1756-8. PubMed ID: 8213720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment with interferon alpha of hemophiliacs with chronic hepatitis C].
    Aguilar Franco C; Lucía Cuesta JF; Simón Marco MA
    Rev Clin Esp; 1996 Oct; 196(10):727-8. PubMed ID: 9005483
    [No Abstract]   [Full Text] [Related]  

  • 7. The cost effectiveness of alpha interferon in the treatment of chronic active hepatitis C.
    Shiell A; Briggs A; Farrell GC
    Med J Aust; 1994 Mar; 160(5):268-72. PubMed ID: 8107627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy noncompliance in chronic viral hepatitis--standard therapy, prognostic parameters, treatment strategy].
    Hopf U
    Praxis (Bern 1994); 1997 Jan; 86(4):83-5. PubMed ID: 9064723
    [No Abstract]   [Full Text] [Related]  

  • 9. Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment.
    Bellobuono A; Mondazzi L; Tempini S; Silini E; Idéo G
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1169-77. PubMed ID: 9471022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection.
    Chayama K; Tsubota A; Kobayashi M; Okamoto K; Hashimoto M; Miyano Y; Koike H; Kobayashi M; Koida I; Arase Y; Saitoh S; Suzuki Y; Murashima N; Ikeda K; Kumada H
    Hepatology; 1997 Mar; 25(3):745-9. PubMed ID: 9049229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of side effects of interferon-alpha in 72 patients treated for chronic active hepatitis C].
    Duché A; Decocq G; Capron-Chivrac D; Andréjak M
    Therapie; 1995; 50(5):419-23. PubMed ID: 8571279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa.
    Zeuzem S; Lee JH; Roth WK
    Hepatology; 1997 Mar; 25(3):740-4. PubMed ID: 9049228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Factors predicting the response to alpha-interferon therapy in patients with chronic hepatitis C].
    Soresi M; Tripi S; Cartabellotta A; di Gaetano G; Carroccio A; Amato S; Migneco G; Montalto G
    Recenti Prog Med; 1996 Apr; 87(4):154-7. PubMed ID: 8643875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of serum hepatitis C virus RNA concentration by branched DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon-alpha therapy in chronic hepatitis C patients.
    Toyoda H; Nakano S; Kumada T; Takeda I; Sugiyama K; Osada T; Kiriyama S; Orito E; Mizokami M
    J Med Virol; 1996 Apr; 48(4):354-9. PubMed ID: 8699168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
    Scand J Infect Dis; 1995; 27(4):319-24. PubMed ID: 8658063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interferon therapy of chronic hepatitis C in hemophilia].
    Frickhofen N; Ellbrück D; Seifried E
    Dtsch Med Wochenschr; 1995 Feb; 120(5):157. PubMed ID: 7843037
    [No Abstract]   [Full Text] [Related]  

  • 17. Intrahepatic expression of c-fos, c-myb and c-myc oncogenes: correlation with virus-induced chronic liver disease and response to interferon.
    Tappero G; Farina M; Negro F; Anfossi G; Mattiello L; Giuli PD; Colombatto P; Brunetto MR; Angeli A; Bonino F
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):148-54. PubMed ID: 9646196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Liver, biliary tracts and human immunodeficiency virus infection. 1:q liver, HIV and hepatitis B, C and D viruses].
    Vuitton DA; Chossegros P; Bresson-Hadni S; Delfraissy JF; Kirn A; Marcellin P; Pol S; Saint-Paul MC
    Gastroenterol Clin Biol; 1996; 20(3):269-80. PubMed ID: 8763066
    [No Abstract]   [Full Text] [Related]  

  • 19. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron.
    Hayashi H; Takikawa T; Nishimura N; Yano M; Isomura T; Sakamoto N
    Am J Gastroenterol; 1994 Jul; 89(7):986-8. PubMed ID: 8017395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-alpha increases prostaglandin E2 production by cultured liver biopsy in patients with chronic viral hepatitis: can non-steroidal anti-inflammatory drugs improve the therapeutic response to interferon?
    Andreone P; Cursaro C; Gasbarrini G
    J Hepatol; 1993 Sep; 19(2):228-31. PubMed ID: 8301055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.